维普期刊资源整合服务平台（V6.5）

21篇 您的检索式：作者名="VASILEIADIS G I"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Thyro- globulin antibodies could be a potential predictive mark- er for papillary thyroid carcinoma显示文摘	Vasileiadis I Boutzios G Charitoudis G	2014	Ann Surg Oncol2014，21，8：	1
2	Bilateral versus uni- lateral papillary thyroid microcarcinoma: predictive factors and asso- ciated histopathological findings following total thyroidectomy 显示文摘	Karatzas T Vasileiadis I Charitoudis G	2013	Hormones ( Athens)2013，12，4：	1
3	Bilateral versus unilateral papillary thyroid microcarcinoma: predictive factors and associated histopathological findings following total thyroidectomy 显示文摘	Karatzas T Vasileiadis I Charitoudis G	2013	Hormones (Athens)2013，12，4：	1
4	Maximum inspiratory pressure,a surrogate parameter for the assessment of ICU-acquired weakness显示文摘	Tzanis G Vasileiadis I Zervakis D	2011	BMC anesthesiology2011，11，：	1
5	Thyroglobulin antibodies could be a potential predictive marker for papillary thyroid carcinoma显示文摘	Vasileiadis I Boutzios G Charitoudis G	2014	Ann Surg Oncol2014，21，8：	1
6	Papillary thyroid mi- crocarcinoma: clinicopathological characteristics and implications for treatment in 276 patients显示文摘	Vasileiadis I Karakostas E Charitoudis G	2012	Eur J Clin Invest2012，42，6：	1
7	Bilateral versus unilateral papillary thyroid microcarcinoma: predictive factors and associated histopathological findings following total thyroidectomy 显示文摘	Karatzas T Vasileiadis I Charitoudis G	2013	Hormones(Athens)2013，12，4：	1
8	Papillary thyroid microcarcinoma: clini- copathological characteristics and implications for treatment in 276 patients显示文摘	VASILEIADIS I KARAKOSTAS E CHARITOU-DIS G	2012	Eur J Clin Invest2012，42，：	1
9	Maximum inspiratory pressure, a surrogate parameter for the assessment of ICU - ac- quired weakness显示文摘	Tzanis G Vasileiadis I Zervakis D	2011	BMC Anesthesiol2011，26，70：	1
10	Papillary thy- roid microcarcinoma: clinicopathological characteristics and impli- cations for treatment in 276 patients显示文摘	Vasileiadis I Karakostas E Charitoudis G	2012	Eur J Clin Invest2012，42，6：	1
11	Maximum inspiratory pressure,a surrogate parameter for the assessment of ICU-acquired weakness显示文摘	Tzanis G Vasileiadis I Zervakis D	2011	BMC Anesthesiol2011，26，7：	1
12	Prevention of heterotopic ossification in cases of hypertrophic osteo- arthritis submitted to total hip arthroplasty 显示文摘	VASILEIADIS G I SAKELLARIOU V I KELEKIS A	2010	J Musculoskelet Neur Interact2010，10，2：	1
13	Maximum inspiratory pressure, a surrogate parameter for the assessment of ICU-acquired weakness 显示文摘	Tzanis G Vasileiadis I Zervakis D	2011	BMC Anesthesiol2011，26，7：	1
14	Papillary thyroid microcarcinomas : clinicopathological characteris- tics and implications for treatment in 276 patients 显示文摘	Vasileiadis I Karakostas E Charitoudis G	2012	Eur J Clin Invest2012，42，6：	1
15	Papillary thyroid microcarcinoma: clinicopathological characteristics and implications for treatment in 276 patients显示文摘	Vasileiadis I Karakostes E Charitoudis G	2012	Eur J Clha Invest2012，42，6：	1
16	Bilateral versus unilateral papillary thyroid microcarcinoma: predictive factors and associated histopathological findings following total thyroidectomy显示文摘	Karatzas T Vasileiadis I Charitoudis G	2013	Hormones (Athens)2013，12，4：	1
17	Papillary thyroid microcarcinoma: clinicopathological characteris- tics and implications for treatment in 276 patients显示文摘	Vasileiadis I Karakostas E Charitoudis G	2012	Eur J Clin Invest2012，42，6：	1
18	Papillary thyroid clinicopathological characteristics and implica- tions for treatment in 276 patients 显示文摘	Vasileiadis I Karakostas E Charitoudis G	2012	Eur J Clin Invest2012，42，6：	1
19	Thyroglobulin antibodies could be a potential predictive marker for papillary thyroid carcinoma显示文摘	Vasileiadis I Boutzios G Charitoudis G	2014	Ann Surg Oncol2014，21，8：	1
20	Maximum inspiratory pressure, a surrogate parameter for the assessment of ICU-acquired weakness显示文摘	Tzanis G Vasileiadis I Zervakis D	2011	BMC Anesthe- siol2011，，11：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示